Ticker LaunchReverse merger · Completed · ERNA
Brooklyn ImmunoTherapeutics LLC
Reverse merger with NTN Buzztime, Inc.
Brooklyn ImmunoTherapeutics LLC merged into NTN Buzztime, Inc., a listed company whose legacy business was sold in an asset sale concurrent with the merger, in a reverse merger that takes the private company public. The deal was announced on Aug 12, 2020 and closed on Mar 25, 2021. The combined company trades as Brooklyn ImmunoTherapeutics, Inc. (now Ernexa Therapeutics) (ERNA) on Nasdaq.
Brooklyn ImmunoTherapeutics is a clinical-stage biopharmaceutical company exploring the role that cytokine-based therapy can have on the immune system, operating through its subsidiary Brooklyn LLC.
- Status
- Completed
- Private company
- Brooklyn ImmunoTherapeutics LLC
- Public company
- NTN Buzztime, Inc.
- Public company business before
- listed company whose legacy business was sold in an asset sale concurrent with the merger
- Announced
- Aug 12, 2020
- Closed
- Mar 25, 2021
- Combined company
- Brooklyn ImmunoTherapeutics, Inc. (now Ernexa Therapeutics) (ERNA)
- Exchange
- Nasdaq
- Sector
- Biotech & pharma
More on this deal for subscribers
- Ownership split between private and public holders
- Reverse stock split
- Analyst notes from the filings
Every record in the database also has its full filing timeline, a daily-updated calendar, watchlist alerts and Excel export.
Then $99/month or $999/year. Cancel anytime.
Filings
- Closing 8-K Mar 31, 2021
- Announcement 8-K Apr 21, 2020
- All filings on EDGAR CIK 748592
Other completed reverse mergers
- MyMD Pharmaceuticals (Florida), Inc.into Akers Biosciences, Inc. · Apr 16, 2021
- 374Water Inc.into PowerVerde, Inc. · Apr 16, 2021
- StemoniX, Inc.into Cancer Genetics, Inc. · Mar 30, 2021
- Chemomab Ltd.into Anchiano Therapeutics Ltd. · Mar 16, 2021
- Envirotech Drive Systems, Inc.into ADOMANI, Inc. · Mar 16, 2021
- Cosmos Capital Limitedinto Wize Pharma, Inc. · Mar 9, 2021